Plain-English translation of NCT06926283 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is an early-stage clinical trial testing a new medication called in patients with prostate cancer and other solid tumors like Ewing sarcoma. The study will evaluate how safe the medication is, what side effects it causes, and whether it helps shrink tumors. Since this is a first-in-human study, researchers are carefully increasing doses to find the right amount that works best.
Many patients with advanced prostate cancer and other solid tumors stop responding to standard treatments and have limited options. This trial exists to explore whether this new medication could offer another treatment path for people in that situation.
You likely qualify if…
You likely don't qualify if…
You would receive the medication as part of a dose escalation study, meaning the dose starts low and gradually increases as researchers monitor safety. You'll have regular clinic visits for blood tests, imaging scans, and check-ups to track how you're responding and watch for side effects. The study is being conducted at multiple hospitals, and you would work with the research team throughout your participation to ensure your safety.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
China